Working… Menu

Efficacy and Safety Study of Aplindore in Patients With Restless Legs Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00834327
Recruitment Status : Terminated (Neurogen acquired by Ligand Pharmaceuticals - no further support for the study. No safety concerns identified.)
First Posted : February 3, 2009
Last Update Posted : October 14, 2009
Information provided by:
Neurogen Corporation

No Study Results Posted on for this Study
Recruitment Status : Terminated
Estimated Primary Completion Date : November 2009
Estimated Study Completion Date : December 2009